PureTech Health is a biotherapeutics company that invents and develops new medicines, largely by creating and growing separate companies around specific scientific ideas. Its work spans areas such as immunology, oncology and the microbiome, and it also develops digital therapeutic products. The company is based in Boston in the United States, and it advances its programmes through its own research teams and through the affiliated businesses it builds, working with partners and investors to move treatments toward patients.
PureTech Health plc trades under the code PRTC on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2209 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
32/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-11.2%
From 52-week high-21.5%
MomentumWeak
26/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-10.9%
6-month return-12.6%
12-month, skipping last month-13.3%
Stability (higher is calmer)Fair
59/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)33.3%
Worst drawdown, 1 year (smaller is calmer)-23.3%
LiquidityStrong
88/100
Trades actively.
See the numbers →
Avg daily value traded86.17M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 106.60 – 143.60Daily closes, split-adjusted
Signals
50-day average116.78
200-day average123.92
Golden/death cross (60d)Death, 57 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.42
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
113.6
Bearish
EMA 10
113.2
Bearish
SMA 20
112.3
Bearish
EMA 20
113.6
Bearish
SMA 50
116.8
Bearish
EMA 50
116.2
Bearish
SMA 100
120.7
Bearish
EMA 100
119.2
Bearish
SMA 200
123.9
Bearish
EMA 200
122.8
Bearish
Oscillators (daily)
RSI (14)
41.34
Neutral
MACD (12, 26)
-0.87
Bearish
Momentum (12)
-0.18
Bearish
Stochastic %K (14)
36.17
Neutral
Williams %R (14)
-63.83
Neutral
CCI (20)
-10.85
Neutral
Pivot points (classic, last session)
S3
102.0
S2
106.0
S1
108.0
Pivot
112.0
R1
114.0
R2
118.0
R3
120.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
